TransCon hGH (lonapegsomatropin)

We are committed to making a meaningful difference for patients with GHD

We are committed to making a meaningful difference for patients with GHD

Vector-Smart-Object-copy

Lonapegsomatropin is an investigational, long-acting human growth hormone prodrug administered weekly that releases somatropin as a potential therapy for children and adults with GHD.

Explore

You are about to access www.ascendispharma.com. Click below if you wish to proceed.